| HF | Heart Failure |
| HTx | Heart Transplant |
| BD | Brain dead |
| PGD | Primary graft dysfunction |
| IRI | Ischemia-reperfusion injury |
| IR | Ischemia-reperfusion |
| MCS | Mechanical circulatory support |
| VAD | Ventricular assist device |
| ECMO | Extracorporeal membrane oxygenation |
| V-A | Veno-arterial |
| PVAD | Percutaneous ventricular assist device |
| IABP | Intra-aortic balloon pump |
| LV | Left ventricle |
| RV | Right ventricle |
| RVF | Right ventricular failure |
| AMI | Acute myocardial infarction |
| PCI | Percutaneous coronary intervention |
| ICT | Intracardiac thrombosis |
| VA | Ventricular arrhythmia |
| AI | Aortic insufficiency |
| MSC | Mesenchymal stromal cells |
| MPC | Mesenchymal precursor cells |
| TAC | Tacrolimus (TAC) |
| CsA | Cyclosporine A |
| MMF | Mycophenolate mofetil |
| AZA | Azathioprine |
| Treg | Regulatory T cells |
| CRS | Cytokine release syndrome |
| GPCR | G protein-coupled receptors |
| ATG | Anti-thymocyte globulin |
| LMWH | Low molecular weight derivatives |
| HLA-G | Human leukocyte antigen-G |
| PGD | Prostaglandin D |
| PGD2 | Prostaglandin D2 |
| MP | Methylprednisolone |
| β-AR | β-adrenoceptors |
| α-AR | α-adrenoceptor |
| GC | Glucocorticoids |